Figure 4.Evaluating PRS signatures in validation sets. (A–C) Risk score distribution and survival status of patients in high- and low-risk groups in validation sets. (D–F) Survival curves in validation sets.
Figure 4 — Construction and evaluation of a nomogram for predicting survival in patients with lung cancer | Aging
